Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaSharon A. Savage, Logan G. Spector, Lindsay M. Morton et al.|JAMA Oncology|2020Cited by 251
Frequency and Implications of Chromosome 8 and 12 Gains in Ewing SarcomaDaniela Maurici, Jonathan A. Fletcher, Antonio R. Pérez‐Atayde et al.|Cancer Genetics and Cytogenetics|1998Cited by 84
Preclinical validation of Aurora kinases-targeting drugs in osteosarcomaElisa Tavanti, Massimo Serra|British Journal of Cancer|2013Cited by 38
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma CellsSerena Vella, Massimo Serra|PLoS ONE|2016Cited by 27